CDK9-IN-24 (compound 21a) is a potent and selective CDK9 inhibitor that significantly inhibits tumor proliferation, impedes cell growth, and triggers apoptosis via downregulation of Mcl-1 and c-Myc, making it valuable for acute myeloid leukemia research.
Molecular Weight:
461.55
Formula:
C27H31N3O4
Target:
CDK
* VAT and and shipping costs not included. Errors and price changes excepted